United Kingdom Pharmaceutical Packaging Market Insight
Published: 25 May 2026 | Report Format: Electronic (PDF)
The UK pharmaceutical packaging market size is rapidly expanding, at about a 8.96% CAGR, and the biologics, vaccine demand, and expanding cold-chain healthcare logistics systems
UK Pharmaceutical Packaging Market Insights Forecasts to 2035
- The UK Pharmaceutical Packaging Market Size Was Estimated at USD 3.232 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 8.96% from 2025 to 2035
- The UK Pharmaceutical Packaging Market Size is Expected to Reach USD 7.623 Million by 2035
Notable Insights for UK Pharmaceutical Packaging Market
- Primary pharmaceutical packaging leads 53% UK pharma packaging share, driven by biologics and injectables demand, supported by USD 1.2–1.5Billion investments in sterile, tamper-evident, and drug protection packaging technologies across healthcare systems.
- The plastic pharmaceutical packaging holds 39% UK market share, driven by lightweight demand and barrier performance, supported by USD 900M–1.05Billion investments in medical-grade polymers, sustainable containers, and advanced pharmaceutical packaging manufacturing systems.
- In the UK life sciences sector exceeds USD 120Billion annually (Office for Life Sciences), driving pharma the packaging demand, supported by USD 3–4Billion investments in cold-chain logistics, compliance packaging, and high-barrier healthcare systems expansion.
Download the eBook (ToC)
- UK government allocates USD 3.5Billion (2024–2026, DHSC) toward healthcare innovation, pharma manufacturing, and vaccine infrastructure, accelerating pharmaceutical packaging modernization, cold-chain expansion, and compliant drug delivery systems across national life sciences ecosystem.
What Makes Decisions Advisors Research Unique?
- Insights into AI-based healthcare packaging market intelligence & industry insight
Decisions Advisors provides you with artificial intelligence-based market intelligence in pharmaceuticals, market analysis, benchmarks, and strategic insights that will help you recognize emerging compliance requirements, sustainable packaging, and pharmaceutical logistics innovations in the United Kingdom pharmaceutical packaging market.
- Market forecasting based on comprehensive research methodology
This market analysis is grounded in pharmaceutical manufacturing statistics, healthcare packaging information, industry research in life sciences, primary interviews, and sophisticated forecasting models to produce trustworthy data on market size, pricing, growth estimates, and prospects for the healthcare packaging industry in the United Kingdom.
- Comprehensive coverage on competition & trends in healthcare packaging market
Our study will bring additional insights about smart pharmaceutical packaging, anti-counterfeiting, sustainable packaging materials, cold chain logistic services, digital tracing methods, and other changes in the United Kingdom pharmaceutical packaging industry.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the UK pharmaceutical packaging market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Pharmaceutical Packaging Market
-
- Amcor plc
- Gerresheimer AG
- West Pharmaceutical Services Inc.
- SCHOTT Pharma
- Berry Global Inc.
- AptarGroup Inc.
- SGD Pharma
- Nipro Corporation
- Others
Recent Developments:
- In October 2025, Gerresheimer AG, Germany, advanced pharmaceutical glass vial technologies. Supported by USD 350M–450Million investments, strengthening biologics containment, sterile injectable packaging, and UK-linked drug delivery systems across European life sciences manufacturing markets.
- In December 2025, Amcor plc, Switzerland, advanced pharmaceutical packaging innovation. Supported by USD 500M–700Million investments, strengthening sterile healthcare packaging, high-barrier medical films, and UK-linked low-carbon pharma supply chains across European life sciences markets.
Market Segmentation:
United Kingdom Pharmaceutical Packaging Market, By Packaging Type
-
- Primary Packaging
- Secondary Packaging
- Tertiary Packaging
United Kingdom Pharmaceutical Packaging Market, By Material Type
-
- Plastic
- Glass
- Aluminum
- Paper & Paperboard
- Others
United Kingdom Pharmaceutical Packaging Market, By Product Type
-
- Bottles
- Blister Packs
- Vials & Ampoules
- Pre-Filled Syringes
- Pouches & Sachets
- Others
United Kingdom Pharmaceutical Packaging Market, By Application
-
- Oral Drugs
- Injectable Drugs
- Topical Medicines
- Biologics
- Vaccines
- Others
Expert Views:
The United Kingdom pharmaceutical packaging market is anticipated to grow at an impressive rate in the years to come because of growing pharmaceutical production, biologics production, and increased healthcare sustainable packaging requirements. The growth in cold chain, anti-counterfeiting technology, and personalized medicine packaging will help sustain the market growth for pharmaceutical packaging.
Author: Sanket and Pranali By Spherical Insights and Consulting